文章摘要
孙榕贺,王云飞.血脂与子宫内膜癌[J].济宁医学院学报,2022,45(3):216-220
血脂与子宫内膜癌
Blood lipids and endometrial cancer
投稿时间:2021-07-11  
DOI:10.3969/j.issn.1000-9760.2022.03.015
中文关键词: 血脂;子宫内膜癌;发生机制;降脂药物
英文关键词: Blood lipids;Endometrial cancer;Mechanism;Lipid-lowering drugs
基金项目:
作者单位E-mail
孙榕贺 济宁医学院临床学院, 济宁 272013

济宁医学院附属医院, 济宁 272029 
 
王云飞 济宁医学院临床学院, 济宁 272013

济宁医学院附属医院, 济宁 272029 
wangyunfei@mail.jnmc.edu.cn 
摘要点击次数: 0
全文下载次数: 0
中文摘要:
      近年来,随着我国生活水平的提升及饮食结构的改变,高血脂的发病率逐年上升,大量研究证实血脂水平与众多肿瘤的发生发展密切相关。子宫内膜癌(endometrial carcinoma,EC)是女性常见的生殖道恶性肿瘤之一,其与血脂的关系也愈加受到关注。血脂可通过PI3K/AKT通路、雌激素、ROS产生等途径促进EC的发生发展,他汀类药物对EC具有一定的抑制作用,但存在不少争议。本文就血脂与EC发生发展、预后的关系以及降脂类药物在EC中的应用研究做一综述,以期为后续的基础和临床研究提供参考。
英文摘要:
      In recent years,with the improvement of living standards and dietary changes,hyperlipidemia has increased year by year in China.A large number of studies have demonstrated that blood lipid levels are closely associated with the occurrence and development of various tumors.Endometrial cancer(EC)is one of the most common malignancies of the female genital tract,and its relationship with blood lipids has also attracted more and more attention.Blood lipids may promote the occurrence and development of endometrial cancer through PI3K/AKT pathway,estrogen,and ROS production.Statins also have a certain inhibitory effect on endometrial cancer,but there are still controversies.In this article,we summarize recent studies on the relationship between hypothyroidism and endometrial cancer and the application of lipid-lowering drugs in endometrial cancer in order to provide references for basic research as well as for clinical treatment.
查看全文   查看/发表评论  下载PDF阅读器

分享按钮

漂浮通知

  X

近期,网上出现以《济宁医学院学报》杂志社的名义制造的虚假网站,诱骗作者在线投稿,骗取作者版面费或收取中介费,造成恶劣影响。在此提醒广大作者,审慎辨别,谨防上当。 投稿警示:我刊对所有来稿均不收取审稿费。 投稿方式:登录济宁医学院官方网站,在左下方点击“济宁医学院学报”进入《济宁医学院学报》网页,点击作者登录,注册新用户,然后在线投稿。